Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes

Glioblastoma multiforme (GBM) is one of the most aggressive primary tumors of the central nervous system. It is associated with a very poor prognosis, with up to half of patients failing to survive the first year after diagnosis. It develops from glial tissue and belongs to the adult-type diffuse gl...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Marcin Jezierzański, Natalia Nafalska, Małgorzata Stopyra, Tomasz Furgoł, Michał Miciak, Jacek Kabut, Iwona Gisterek-Grocholska
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2024-07-01
Sarja:	Current Oncology
Aiheet:	temozolomide: glioblastoma multiforme anticancer therapy effectiveness overall survival
Linkit:	https://www.mdpi.com/1718-7729/31/7/296
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!